Quarterly report · Q1
9265.TEDINET S100PBDN
Period2022-06-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.5bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2021-06-01 → 2021-08-31 | Cons. | Net sales |
| Operating income | ¥259m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥202m | 2021-06-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥274m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥221m | 2021-06-01 → 2021-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥281m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥225m | 2021-06-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥165m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥144m | 2021-06-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥163m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥144m | 2021-06-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥23.0bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥24.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥22.2bn | at 2021-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.0bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥16.1bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.5bn | at 2021-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥64.7 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.52 | 2021-06-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.8% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.8% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2022-08-31 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2022-08-31 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-08-31 | −¥233m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥71m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥71m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥5m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥13.4bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥13.4bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥11m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥487m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥0 |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥13.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥13.5bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥11m |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥493m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2021-08-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2021-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2021-08-31 | −¥208m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥72m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥72m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2021-06-01 → 2021-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥5m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥12.8bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥12.8bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2021-06-01 → 2021-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥404m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥1m |
| —segment total | revenue | 2021-06-01 → 2021-08-31 | ¥12.9bn |
| —segment total | revenue external | 2021-06-01 → 2021-08-31 | ¥12.9bn |
| —segment total | revenue intersegment | 2021-06-01 → 2021-08-31 | ¥0 |
| —segment total | segment profit | 2021-06-01 → 2021-08-31 | ¥411m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 340
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes and accounts payable trade | Prior1YearInstant | 7896000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 8557000000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 6006000000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 5054000000 | JPY |
| Income taxes payable | Prior1YearInstant | 127000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 10000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 635000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 98000000 | JPY |
| Other cl | Prior1YearInstant | 889000000 | JPY |
| Other cl | CurrentQuarterInstant | 630000000 | JPY |
| Current liabilities | Prior1YearInstant | 15555000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 14352000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 237000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 230000000 | JPY |
| Other ncl | Prior1YearInstant | 287000000 | JPY |
| Other ncl | CurrentQuarterInstant | 397000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 525000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 627000000 | JPY |
| Liabilities | Prior1YearInstant | 16081000000 | JPY |
| Liabilities | CurrentQuarterInstant | 14979000000 | JPY |
| Capital stock | Prior1YearInstant | 494000000 | JPY |
| Capital stock | CurrentQuarterInstant | 494000000 | JPY |
| Capital surplus | Prior1YearInstant | 627000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 627000000 | JPY |
| Retained earnings | Prior1YearInstant | 6296000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 6252000000 | JPY |
| Treasury stock | Prior1YearInstant | -0 | JPY |
| Treasury stock | CurrentQuarterInstant | -0 | JPY |
| Shareholders equity | Prior1YearInstant | 7417000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 7373000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 651000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 722000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -88000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -83000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 562000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 639000000 | JPY |
| Non controlling interests | Prior1YearInstant | 24000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 22000000 | JPY |
| Net assets | Prior1YearInstant | 8005000000 | JPY |
| Net assets | CurrentQuarterInstant | 8036000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 24086000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 23016000000 | JPY |
| Net sales | Prior1YTDDuration | 12885000000 | JPY |
| Net sales | CurrentYTDDuration | 13471000000 | JPY |
| Cost of sales | Prior1YTDDuration | 11171000000 | JPY |
| Cost of sales | CurrentYTDDuration | 11625000000 | JPY |
| Gross profit | Prior1YTDDuration | 1713000000 | JPY |
| Gross profit | CurrentYTDDuration | 1846000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 1511000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 1586000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |